June 23, 2023
- July 30, 2021 - Clinical and Translational Science Award (UM1 Clinical Trial Optional) See NOFO PAR-21-293
National Center for Advancing Translational Sciences (NCATS)
The purpose of this Notice is to inform potential applicants of the updates in the Award Information for PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) for receipt dates of January 12, 2024, May 17, 2024 and September 13, 2024.
Section II. Award Information
Award Budget
Currently Reads:
The amount of funding that applicants can request depends on the amount of NIH funding they receive. After calculating the total amount of NIH funding received as described in Section IV. Application and Submission Information, 2. Content and Form of Application Submission, R&R Budget, applicants may request the following amounts:
Size Eligibility Budget Tiers for FOA Applicants | Maximum Direct Cost Budget Requests for UM1 | |
Hub Tier | 5-year average of the most current NIH Direct Cost (DC) Funding of the applicant institution, PLUS 5-year average of the most current NIH Direct Cost (DC) funding of any partner(s)* (based on FY2017-FY2021 NIH Funding data) | UM1 |
A | >$320,000,000 | $6,500,000 |
C | $235,000,000 - $320,000,000 | $5,000,000 |
T | $145,000,000 - $234,999,999 | $3,600,000 |
G | <$145,000,000 | $2,600,000 |
Revised to Read:
Award Budget
The amount of funding that applicants can request depends on the amount of NIH funding they receive. After calculating the total amount of NIH funding received as described in Section IV. Application and Submission Information, 2. Content and Form of Application Submission, R&R Budget, applicants may request the following amounts:
Size Eligibility Budget Tiers for FOA Applicants | Maximum Direct Cost Budget Requests for UM1 | |
Hub Tier | 5-year average of the most current NIH Direct Cost (DC) Funding of the applicant institution, PLUS 5-year average of the most current NIH Direct Cost (DC) funding of any partner(s)* (based on FY2018-FY2022 NIH Funding data) | UM1 |
A | >$340,000,000 | $6,500,000 |
C | $250,000,000 - $339,999,999 | $5,000,000 |
T | $155,000,000 - $249,999,999 | $3,600,000 |
G | <$155,000,000 | $2,600,000 |
All other aspects of the Notice of Funding Opportunity remain unchanged.
Inquiries
Please direct all inquiries to:
Erica Rosemond, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-594-8927
Email: [email protected]
and Human Services (HHS)
